Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
136.66
+0.94 (0.69%)
At close: Dec 18, 2025, 4:00 PM EST
136.66
0.00 (0.00%)
After-hours: Dec 18, 2025, 5:48 PM EST

Masimo Revenue

Masimo had revenue of $371.50M in the quarter ending September 27, 2025, with 8.21% growth. This brings the company's revenue in the last twelve months to $2.18B, up 38.48% year-over-year. In the year 2024, Masimo had annual revenue of $2.09B with 2.26% growth.

Revenue (ttm)
$2.18B
Revenue Growth
+38.48%
P/S Ratio
3.36
Revenue / Employee
$606,111
Employees
3,600
Market Cap
7.34B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 20242.09B46.30M2.26%
Dec 30, 20232.05B12.30M0.60%
Dec 31, 20222.04B796.60M64.28%
Jan 1, 20221.24B95.50M8.35%
Jan 2, 20211.14B205.86M21.95%
Dec 28, 2019937.84M79.55M9.27%
Dec 29, 2018858.29M68.04M8.61%
Dec 30, 2017790.25M95.62M13.77%
Dec 31, 2016694.63M64.51M10.24%
Jan 2, 2016630.11M43.47M7.41%
Jan 3, 2015586.64M39.40M7.20%
Dec 28, 2013547.25M54.01M10.95%
Dec 29, 2012493.23M54.25M12.36%
Dec 31, 2011438.99M33.58M8.28%
Jan 1, 2011405.41M56.29M16.12%
Jan 2, 2010349.12M42.04M13.69%
Jan 3, 2009307.07M50.79M19.82%
Dec 29, 2007256.29M31.95M14.24%
Dec 31, 2006224.34M116.45M107.93%
Dec 31, 2005107.89M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings